Endocrinology / diabetes clinical trials recruiting in Pennsylvania

298 recruiting endocrinology / diabetes trials match in Pennsylvania. Showing 20.

• Diabetes Clinical Decision SupportRecruiting

  N/A · Milton S. Hershey Medical Center · Hershey, Pennsylvania

• A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsRecruiting

  Phase 1 · Context Therapeutics Inc. · Little Rock, Arkansas

• A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult ParticipantsRecruiting

  Phase 2 / Phase 3 · AbbVie · Feasterville-Trevose, Pennsylvania

• ETHAN - ET for Male BCRecruiting

  Phase 2 · Jose Pablo Leone · Philadelphia, Pennsylvania

• CGM for Management of Type 2 Diabetes in PregnancyRecruiting

  N/A · University of Alabama at Birmingham · Philadelphia, Pennsylvania

• Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLRecruiting

  Phase 2 · Etan Orgel · Philadelphia, Pennsylvania

• A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)Recruiting

  Phase 2 / Phase 3 · Crinetics Pharmaceuticals Inc. · Philadelphia, Pennsylvania

• The Myelin Disorders Biorepository ProjectRecruiting

  N/A · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania

• Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCRecruiting

  Phase 2 · Massachusetts General Hospital · Philadelphia, Pennsylvania

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Pittsburgh, Pennsylvania

• TTX-080 HLA-G Antagonist in Subjects With Advanced CancersRecruiting

  Phase 1 · Tizona Therapeutics, Inc · Denver, Colorado

• A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone TreatmentRecruiting

  Phase 2 · BioMarin Pharmaceutical · Philadelphia, Pennsylvania

• Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney DiseaseRecruiting

  Phase 2 · Regeneron Pharmaceuticals · Bethlehem, Pennsylvania

• FTT PET/CT in Pancreatic Neuroendocrine TumorsRecruiting

  Phase 1 · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania

• Feasibility of Semaglutide in Advanced Lung DiseaseRecruiting

  Phase 1 / Phase 2 · University of Pennsylvania · Philadelphia, Pennsylvania

• Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerRecruiting

  Phase 2 · National Cancer Institute (NCI) · Pittsburgh, Pennsylvania

• Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsRecruiting

  Phase 1 · Xencor, Inc. · Pittsburgh, Pennsylvania

• Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsRecruiting

  Phase 2 / Phase 3 · Exelixis · Philadelphia, Pennsylvania

• Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)Recruiting

  Phase 3 · NX Development Corp · York, Pennsylvania

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Recruiting

  Phase 2 / Phase 3 · CSL Behring · Bethlehem, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.